Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,030.00
-240.00 (-2.90%)
Last updated: Sep 16, 2025, 11:29 AM KST
-2.90%
Market Cap30.29B
Revenue (ttm)24.49B
Net Income (ttm)-737.44M
Shares Out3.80M
EPS (ttm)-194.06
PE Ration/a
Forward PEn/a
Dividend75.00 (0.94%)
Ex-Dividend DateDec 27, 2024
Volume11,724
Average Volume8,758
Open8,270.00
Previous Close8,270.00
Day's Range7,970.00 - 8,280.00
52-Week Range7,620.00 - 11,060.00
Beta0.56
RSI50.83
Earnings DateNov 13, 2025

About KOSDAQ:036480

Daesung Microbiological Labs. Co., Ltd. manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea. It offers antibiotics and antibacterials, parasiticides and disinfectants, probiotics and enzyme products, and nutrients and pharmaceuticals. The company also exports its products. Daesung Microbiological Labs. Co., Ltd. was founded in 1966 and is headquartered in Uiwang-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1966
Employees 134
Stock Exchange KOSDAQ
Ticker Symbol 036480
Full Company Profile

Financial Performance

In 2024, KOSDAQ:036480's revenue was 23.80 billion, a decrease of -6.88% compared to the previous year's 25.56 billion. Losses were -1.77 billion, 160.3% more than in 2023.

Financial Statements

News

There is no news available yet.